Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Masimo Corporation - Common Stock (NQ:MASI)

175.35 -0.26 (-0.15%)
Streaming Delayed Price Updated: 2:59 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
News headline image
Masimo's Skyrocketing Growth: Analyst Boosts Price Target Amid Exciting New Ventures ↗
 
Via Benzinga
News headline image
Masimo: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Masimo Reports First Quarter 2023 Financial Results
From Masimo
Via Business Wire
News headline image
A Preview Of Masimo's Earnings ↗
 
Via Benzinga
News headline image
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
From Masimo
Via Business Wire
Masimo Corp. (NASDAQ: MASI) Records 52-Week High Thursday Morning
Via Investor Brand Network
News headline image
Expert Ratings for Masimo ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Politan Nominates Two Candidates for Masimo Board
From Politan Capital Management
Via Business Wire
News headline image
Masimo Stork™ Delivers State-of-the-Art Baby Monitoring to the Home
From Masimo
Via Business Wire
News headline image
Masimo to Report First Quarter 2023 Financial Results After Market Close on Tuesday, May 9
From Masimo
Via Business Wire
News headline image
Masimo Announces FDA Clearance of the Rad-G® with Temperature
From Masimo
Via Business Wire
News headline image
Shockwave Medical Stock With Rising Relative Strength ↗
On Tuesday, Shockwave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 67 to 75. 
Via Investor's Business Daily
News headline image
Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System
From Masimo
Via Business Wire
News headline image
Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch
From Masimo
Via Business Wire
News headline image
Masimo Announces Changes to Governance Structure and Practices
From Masimo Corporation
Via Business Wire
News headline image
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
From Masimo
Via Business Wire
News headline image
New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
From Masimo
Via Business Wire
News headline image
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
From Masimo
Via Business Wire
News headline image
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
From Masimo
Via Business Wire
News headline image
$300B California Teachers Pension Fund Joins Politan Capital In Legal Action Against Masimo CEO's Employment Agreement ↗
 
Via Benzinga
News headline image
CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO’s Employment Agreement
From Politan Capital Management
Via Business Wire
News headline image
Masimo to Present in 44th Annual Raymond James Institutional Investors Conference
From Masimo
Via Business Wire
News headline image
Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results
From Masimo
Via Business Wire
News headline image
Analyst Says This MedTech Giant Stock Offers 'Too Much Optionality,' Upgrades Rating ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 ↗
 
Via Benzinga
News headline image
New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
From Masimo
Via Business Wire
News headline image
Masimo Centroid® Receives Innovative Technology Designation from Vizient
From Masimo
Via Business Wire
News headline image
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
From Masimo
Via Business Wire
News headline image
Thoughts For Thursday: Risk-off, Risk-on ↗
The one foot forward, one foot backward action continues on Wall Street, though yesterday it was more like three or four steps backward. It seems Q1 earnings jitters are responsible. 
Via Talk Markets
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.